[go: up one dir, main page]

NO20052291D0 - Nye bicyklsike inhibitorer av hormonsensitiv lipase - Google Patents

Nye bicyklsike inhibitorer av hormonsensitiv lipase

Info

Publication number
NO20052291D0
NO20052291D0 NO20052291A NO20052291A NO20052291D0 NO 20052291 D0 NO20052291 D0 NO 20052291D0 NO 20052291 A NO20052291 A NO 20052291A NO 20052291 A NO20052291 A NO 20052291A NO 20052291 D0 NO20052291 D0 NO 20052291D0
Authority
NO
Norway
Prior art keywords
hormone
sensitive lipase
novel bicyclic
bicyclic inhibitors
inhibitors
Prior art date
Application number
NO20052291A
Other languages
English (en)
Norwegian (no)
Other versions
NO20052291L (no
Inventor
Guenter Mueller
Hubert Heuer
Karl-Heinz Baringhaus
Stefan Petry
Norbert Nagels
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of NO20052291L publication Critical patent/NO20052291L/no
Publication of NO20052291D0 publication Critical patent/NO20052291D0/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/16Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C07D249/18Benzotriazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20052291A 2002-10-12 2005-05-10 Nye bicyklsike inhibitorer av hormonsensitiv lipase NO20052291D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10247680A DE10247680B4 (de) 2002-10-12 2002-10-12 Neue bicyclische Inhibitoren der Hormon Sensitiven Lipase
PCT/EP2003/010765 WO2004035550A1 (de) 2002-10-12 2003-09-27 Neue bicyclische inhibitoren der hormon sensitiven lipase

Publications (2)

Publication Number Publication Date
NO20052291L NO20052291L (no) 2005-05-10
NO20052291D0 true NO20052291D0 (no) 2005-05-10

Family

ID=32038583

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052291A NO20052291D0 (no) 2002-10-12 2005-05-10 Nye bicyklsike inhibitorer av hormonsensitiv lipase

Country Status (38)

Country Link
EP (1) EP1554259B1 (zh)
JP (2) JP4658607B2 (zh)
KR (1) KR20050059254A (zh)
CN (1) CN100366616C (zh)
AR (1) AR041565A1 (zh)
AT (1) ATE349433T1 (zh)
AU (1) AU2003275997B8 (zh)
BR (1) BR0315257A (zh)
CA (1) CA2501734C (zh)
CR (1) CR7717A (zh)
CY (1) CY1106358T1 (zh)
DE (2) DE10247680B4 (zh)
DK (1) DK1554259T3 (zh)
EC (1) ECSP055729A (zh)
ES (1) ES2277152T3 (zh)
GT (1) GT200300214A (zh)
HN (1) HN2003000316A (zh)
HR (1) HRP20050325A2 (zh)
IL (1) IL167907A (zh)
JO (1) JO2497B1 (zh)
MA (1) MA27404A1 (zh)
MX (1) MXPA05003359A (zh)
MY (1) MY138057A (zh)
NO (1) NO20052291D0 (zh)
OA (1) OA12941A (zh)
PA (1) PA8585101A1 (zh)
PE (1) PE20040776A1 (zh)
PL (1) PL374605A1 (zh)
PT (1) PT1554259E (zh)
RS (1) RS51543B (zh)
RU (1) RU2325385C2 (zh)
SV (1) SV2004001633A (zh)
TN (1) TNSN05105A1 (zh)
TW (1) TWI313265B (zh)
UA (1) UA79994C2 (zh)
UY (1) UY28015A1 (zh)
WO (1) WO2004035550A1 (zh)
ZA (1) ZA200501757B (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005002130A1 (de) 2005-01-17 2006-07-27 Sanofi-Aventis Deutschland Gmbh Substituierte N-Aminomethylensulfonamide, ihre Herstellung und Verwendung als Arzneimittel
DE102005026808A1 (de) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzooxazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026762A1 (de) 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005026809A1 (de) 2005-06-09 2006-12-14 Sanofi-Aventis Deutschland Gmbh Benzothiazol-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005048897A1 (de) 2005-10-12 2007-04-19 Sanofi-Aventis Deutschland Gmbh Diacylindazol-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049954A1 (de) * 2005-10-19 2007-05-31 Sanofi-Aventis Deutschland Gmbh Triazolopyridin-derivate als Inhibitoren von Lipasen und Phospholipasen
DE102005049953A1 (de) 2005-10-19 2007-04-26 Sanofi-Aventis Deutschland Gmbh Carbamoylbenzotriazol-derivate als Inhibitoren von Lipasen und Phospholipasen
FR2915199B1 (fr) 2007-04-18 2010-01-22 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyrimidine-carboxamides, leur preparation et leur application en therapeutique.
FR2915198B1 (fr) 2007-04-18 2009-12-18 Sanofi Aventis Derives de triazolopyridine-carboxamides et triazolopyridine -carboxamides, leur preparation et leur application en therapeutique.
FR2915197B1 (fr) * 2007-04-18 2009-06-12 Sanofi Aventis Sa Derives de triazolopyridine-carboxamides, leur preparation et leur application therapeutique.
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
AR075111A1 (es) * 2008-12-24 2011-03-09 Bial Portela & Ca Sa Derivados heterociclicos de diazoles y triazoles, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de trastornos del metabolismo y del sistema nervioso, entre otros.
US8329904B2 (en) * 2009-05-12 2012-12-11 Hoffmann-La Roche Inc. Azacyclic derivatives
US8440710B2 (en) * 2009-10-15 2013-05-14 Hoffmann-La Roche Inc. HSL inhibitors useful in the treatment of diabetes
US8097634B2 (en) * 2010-04-15 2012-01-17 Hoffmann-La Roche Inc. Azacyclic derivatives
US8450350B2 (en) * 2010-05-05 2013-05-28 Infinity Pharmaceuticals, Inc. Triazoles as inhibitors of fatty acid synthase
US8722721B2 (en) * 2011-03-16 2014-05-13 Hoffmann-La Roche Inc. SEC-hydroxycyclohexyl derivatives
US8703807B2 (en) * 2011-03-17 2014-04-22 Hoffmann-La Roche Inc. Azaspirodecanone compounds
US8809384B2 (en) 2011-03-25 2014-08-19 Hoffmann-La Roche Inc. Azaspirodecanone compounds
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
GB201321740D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic agents
WO2015089137A1 (en) 2013-12-11 2015-06-18 Karos Pharmaceuticals, Inc. Acylguanidines as tryptophan hydroxylase inhibitors
WO2016109501A1 (en) 2014-12-30 2016-07-07 Karos Pharmaceuticals, Inc. Amide compounds as tryptophan hydroxylase inhibitors
US9611201B2 (en) 2015-03-05 2017-04-04 Karos Pharmaceuticals, Inc. Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
US11203597B2 (en) 2018-11-14 2021-12-21 Altavant Sciences Gmbh Crystalline spirocyclic compound, a dosage form containing, a method for using in treatment of disease, and a method for recrystallizing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1124716A (en) * 1978-10-20 1982-06-01 Michael J. Simons Blocked benzotriazole compounds as development restrainer precursors
US5369086A (en) * 1993-04-28 1994-11-29 Zeneca Limited N-benzotriazoles
DE19942354A1 (de) * 1999-09-04 2001-03-08 Aventis Pharma Gmbh Substituierte 3-Phenyl-5-alkoxi-1,3,4-oxdiazol-2-one, ihre Herstellung und Verwendung in Arzneimitteln
MXPA03010129A (es) * 2001-05-05 2004-03-10 Smithkline Beecham Plc N-aroilaminas-ciclicas.
EP1458374A2 (en) * 2001-12-14 2004-09-22 Novo Nordisk A/S Compounds and uses thereof for decreasing activity of hormone-sensitive lipase

Also Published As

Publication number Publication date
KR20050059254A (ko) 2005-06-17
SV2004001633A (es) 2004-03-19
MY138057A (en) 2009-04-30
CA2501734A1 (en) 2004-04-29
ES2277152T3 (es) 2007-07-01
RU2325385C2 (ru) 2008-05-27
DK1554259T3 (da) 2007-05-07
JP2011026342A (ja) 2011-02-10
RS51543B (sr) 2011-06-30
HK1080473A1 (zh) 2006-04-28
CR7717A (es) 2007-09-14
DE50306134D1 (de) 2007-02-08
CA2501734C (en) 2011-05-31
PT1554259E (pt) 2007-02-28
NO20052291L (no) 2005-05-10
TNSN05105A1 (en) 2007-05-14
ZA200501757B (en) 2005-09-07
WO2004035550A1 (de) 2004-04-29
HN2003000316A (es) 2006-06-12
CN100366616C (zh) 2008-02-06
HRP20050325A2 (en) 2005-06-30
JP4658607B2 (ja) 2011-03-23
EP1554259B1 (de) 2006-12-27
UA79994C2 (en) 2007-08-10
TWI313265B (en) 2009-08-11
JO2497B1 (en) 2009-10-05
TW200413335A (en) 2004-08-01
AU2003275997B8 (en) 2010-09-30
PE20040776A1 (es) 2004-12-24
IL167907A (en) 2010-12-30
AU2003275997A1 (en) 2004-05-04
GT200300214A (es) 2007-02-05
MA27404A1 (fr) 2005-06-01
EP1554259A1 (de) 2005-07-20
JP2006509734A (ja) 2006-03-23
DE10247680A1 (de) 2004-04-22
RU2005114394A (ru) 2006-01-20
RS20050207A (sr) 2007-08-03
OA12941A (en) 2006-10-13
AU2003275997B2 (en) 2010-03-25
PL374605A1 (en) 2005-10-31
UY28015A1 (es) 2004-04-30
DE10247680B4 (de) 2005-09-01
CN1688555A (zh) 2005-10-26
AR041565A1 (es) 2005-05-18
CY1106358T1 (el) 2011-10-12
PA8585101A1 (es) 2004-09-16
BR0315257A (pt) 2005-08-23
MXPA05003359A (es) 2005-06-22
ATE349433T1 (de) 2007-01-15
ECSP055729A (es) 2005-07-06

Similar Documents

Publication Publication Date Title
NO20052291D0 (no) Nye bicyklsike inhibitorer av hormonsensitiv lipase
NO20050072L (no) Nye inhibitorer av kinaser
NO20050636L (no) Inhibitorer av tyrosinkinaser
EP1517904A4 (en) INHIBITORS OF MITOTIC KINESINE
EP1509507A4 (en) INHIBITORS OF MITOTIC KINESINE
EP1578724A4 (en) INHIBITORS OF MITOTIC KINESINE
NO20043695L (no) Selektive dipeptidinhibitorer av kallikrein
AU2003251559A8 (en) Heterocyclic inhibitors of kinases
DE502005011241D1 (de) Indazolderivate als inhibitoren der hormon-sensitiven lipase
AU2003215112A8 (en) Novel bicyclic hydroxamates as inhibitors of histone deacetylase
SE530720E (sv) Förbehandling av flis med höggradig defibrering
EP1656133A4 (en) INHIBITORS OF MITOTIC KINESINE
EP1474093A4 (en) Granzyme B INHIBITORS
EP1549316A4 (en) HAMMER OF TFGbeta
EP1656146A4 (en) INHIBITORS OF MITOTIC KINESINE
NO20050118D0 (no) Substituerte fenylsulfonamidinhibitorer av beta-amyolid produksjon
NO20052348D0 (no) Behandling av hemoragisk sjokk
EP1660436A4 (en) cathepsin inhibitors
ATE382048T1 (de) Pyrazolopyrimdine als hemmstoffe cyclin abhängiger kinasen
NO20042679L (no) Inhibitorer av cytosolisk fosfolipase A2
IL165475A0 (en) Nitrooxyderivatives of eyclooxygenase-2 inhibitors
EP1697331A4 (en) INHIBITORS OF MITOTIC KINESINE
EP1613311A4 (en) HIF-1 INHIBITORS
PL373379A1 (en) N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
EP1772148A4 (en) Lipase inhibitors

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application